Clinical Trial Details

TRANSFORM-HF

TRANSFORM-HF: Torsemide Comparison with Furosemide for Management of Heart Failure

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Heart Failure
Study Type: Interventional
Phase: Phase III
Study Start Date: 07/11/2018
Study Completion Date: 08/14/2022

This trial compares Torsemide versus Furosemide on long-term clinical outcomes among patients hospitalized for heart failure.

NCT Number

NCT03296813

Principal Investigator(s)

Geetha Pinto, MD

Sponsor(s)

Duke University

Participant Eligibility

• Age: 18+
• Gender: Male, Female